1
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis
Condition(s):Ulcerative ColitisLast Updated:January 4, 2022Terminated
Janus Kinase Inhibitors as an Intervention: 232 Clinical Trials, Page 1 of 24
Hide Studies Not Open or Pending
2
JAK Inhibition in Ulcerative Colitis
Condition(s):Colitis, UlcerativeLast Updated:December 22, 2022Recruiting
3
A Study to Evaluate JAK Inhibitor Cream in EGFR-inhibitor-induced Skin Rash
Condition(s):Acneiform EruptionsLast Updated:March 2, 2023Active, not recruiting
4
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
Condition(s):Abatacept; Treatment Compliance; Rheumatoid ArthritisLast Updated:September 23, 2022Recruiting
5
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
Condition(s):Dermatomyositis, Adult TypeLast Updated:July 19, 2021Recruiting
6
PANLAR’s Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors
Condition(s):Arthritis, Rheumatoid; Arthritis, Psoriatic; SpondyloarthritisLast Updated:March 29, 2021Recruiting
7
Ruxolitinib for Acute Respiratory Disorder Syndrome Due to COVID-19
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV2Last Updated:April 8, 2021Terminated
8
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Condition(s):Immunoclassification; PsoriasisLast Updated:August 17, 2022Recruiting
9
The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients
Condition(s):Rheumatoid ArthritisLast Updated:March 15, 2023Withdrawn
10
Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis
Condition(s):Rheumatoid ArthritisLast Updated:October 12, 2022Not yet recruiting